Search Constraints
Search Results
Select an image to start the slideshow
Studying the combination of CAR T cells and ICI for treatment of Melanoma
1 of 23
Characterizing the role of recurrent histone H3 mutations in cancer initiation
2 of 23
LCMT-1 is a negative regulator of inflammation and cancer-related signaling pathways
3 of 23
Evaluation of tumor membrane vesicle (TMV) vaccine immunotherapy in a HER2+ TUBO murine breast cancer model
4 of 23
DNA Methylation of CD4+ T-cells Reveals Association of ITGB7 in Pediatric Crohn’s Disease
5 of 23
Dynamic Expression Patterns of PRAP1 During Murine Gestation
6 of 23
Investigating the Roles of ACLY in Multiple Myeloma Biology and Drug Sensitivity
7 of 23
Induction of anti-tumor immunity by vaccine immunotherapy in murine lung cancer models
8 of 23
Investigation of a Xenogenic Vaccine in a Murine Breast Cancer
Model
9 of 23
Characterization of Kell Glycoprotein Transgenic Mice: Murine Model
for Immune Response to Transfusion
10 of 23
Ploidy and Allelic Variation Affects Fungal Pathogen Virulence
in a Nematode Host
11 of 23
An Essential Role for MYST5 (CG1894) in Histone H4 Acetylation and
RNA Polymerase II Pause Release
12 of 23
Delayed Treadmill Training and Synaptic Stripping of Axotomized
Motoneurons
13 of 23
Metabolism of CD4+ Th1 and Th2 cells
14 of 23
Antitumor Effects of Progesterone Alone and in Combination with Temozolomide Against Neurogenic Tumors
15 of 23
Determining the role of the Galectin-3 N-terminus in tumor-specifica poptosis of human glioblastoma cells
16 of 23
Induction of Anti-Tumor Immunity in an Immune Checkpoint
Inhibitor Resistant Murine Lung Cancer
17 of 23
Evaluating the Sensitivity and Specificity of Dried Blood Spots by
Real-Time PCR for the Common Protein Gene, lytA, of
Streptococcus pneumoniae in Diagnosing Pneumococcal
Disease
18 of 23
Conserved signaling mechanisms in the D. melanogaster cellular
immune response
19 of 23
The Role of PD-1 in regulating CD8 T cell response in LCMV
infection
20 of 23
USE OF INTEGRIN BLOCKADE TO INHIBIT CD8+ MEMORY T CELLS IN SOLID
ORGAN TRANSPLANTATION
21 of 23
Graft versus Host Disease and Donor T cell Activation Is Limited by Vasoactive Intestinal Peptide Synthesis by Host Non-hempatopoietic Cells
22 of 23
Vasoactive Intestinal Peptide Antagonist Enhances T cell Proliferation and Synergizes with PD-1 Antibodies to Promote Anti-Melanoma T cell Immune Responses
23 of 23